Cargando…
Hidden Treasures: Macrophage Long Non-Coding RNAs in Lung Cancer Progression
SIMPLE SUMMARY: Cancer immunotherapy mainly targets immune system components, such as immune-suppressive networks generated by cancer cells in the tumor microenvironment (TME). Programmed cell death ligand 1, which is a secretory immune-suppressive factor, is released by tumor-associated macrophages...
Autores principales: | , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8392679/ https://www.ncbi.nlm.nih.gov/pubmed/34439281 http://dx.doi.org/10.3390/cancers13164127 |
_version_ | 1783743559915012096 |
---|---|
author | Karger, Annika Nandigama, Rajender Stenzinger, Albrecht Grimminger, Friedrich Pullamsetti, Soni Savai Seeger, Werner Savai, Rajkumar |
author_facet | Karger, Annika Nandigama, Rajender Stenzinger, Albrecht Grimminger, Friedrich Pullamsetti, Soni Savai Seeger, Werner Savai, Rajkumar |
author_sort | Karger, Annika |
collection | PubMed |
description | SIMPLE SUMMARY: Cancer immunotherapy mainly targets immune system components, such as immune-suppressive networks generated by cancer cells in the tumor microenvironment (TME). Programmed cell death ligand 1, which is a secretory immune-suppressive factor, is released by tumor-associated macrophages (TAMs). The TME also disrupts production of tumor-specific T cells and generates immunosuppressive leukocytes, regulatory T cells, and myeloid-derived suppressor cells. Immune checkpoint inhibitors are effective in various cancers but only in a subset of patients. Non-coding RNAs, such as microRNAs (miRNAs), long non-coding RNAs (lncRNAs), and circular RNAs (circRNAs), are dysregulated in cancer through transcriptional, post-transcriptional, and epigenetic changes and have significant roles in cancer initiation and progression, which depends on deregulation of lncRNA expression. TAM function can be influenced by lncRNAs in various ways. However, our understanding of lncRNA dysregulation and function in cancer remains in the early stage. ABSTRACT: Ever since RNA sequencing of whole genomes and transcriptomes became available, numerous RNA transcripts without having the classic function of encoding proteins have been discovered. Long non-coding RNAs (lncRNAs) with a length greater than 200 nucleotides were considered as “junk” in the beginning, but it has increasingly become clear that lncRNAs have crucial roles in regulating a variety of cellular mechanisms and are often deregulated in several diseases, such as cancer. Lung cancer is the leading cause of cancer-related deaths and has a survival rate of less than 10%. Immune cells infiltrating the tumor microenvironment (TME) have been shown to have a great effect on tumor development with macrophages being the major cell type within the TME. Macrophages can inherit an inflammatory M1 or an anti-inflammatory M2 phenotype. Tumor-associated macrophages, which are predominantly polarized to M2, favor tumor growth, angiogenesis, and metastasis. In this review, we aimed to describe the complex roles and functions of lncRNAs in macrophages and their influence on lung cancer development and progression through the TME. |
format | Online Article Text |
id | pubmed-8392679 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-83926792021-08-28 Hidden Treasures: Macrophage Long Non-Coding RNAs in Lung Cancer Progression Karger, Annika Nandigama, Rajender Stenzinger, Albrecht Grimminger, Friedrich Pullamsetti, Soni Savai Seeger, Werner Savai, Rajkumar Cancers (Basel) Review SIMPLE SUMMARY: Cancer immunotherapy mainly targets immune system components, such as immune-suppressive networks generated by cancer cells in the tumor microenvironment (TME). Programmed cell death ligand 1, which is a secretory immune-suppressive factor, is released by tumor-associated macrophages (TAMs). The TME also disrupts production of tumor-specific T cells and generates immunosuppressive leukocytes, regulatory T cells, and myeloid-derived suppressor cells. Immune checkpoint inhibitors are effective in various cancers but only in a subset of patients. Non-coding RNAs, such as microRNAs (miRNAs), long non-coding RNAs (lncRNAs), and circular RNAs (circRNAs), are dysregulated in cancer through transcriptional, post-transcriptional, and epigenetic changes and have significant roles in cancer initiation and progression, which depends on deregulation of lncRNA expression. TAM function can be influenced by lncRNAs in various ways. However, our understanding of lncRNA dysregulation and function in cancer remains in the early stage. ABSTRACT: Ever since RNA sequencing of whole genomes and transcriptomes became available, numerous RNA transcripts without having the classic function of encoding proteins have been discovered. Long non-coding RNAs (lncRNAs) with a length greater than 200 nucleotides were considered as “junk” in the beginning, but it has increasingly become clear that lncRNAs have crucial roles in regulating a variety of cellular mechanisms and are often deregulated in several diseases, such as cancer. Lung cancer is the leading cause of cancer-related deaths and has a survival rate of less than 10%. Immune cells infiltrating the tumor microenvironment (TME) have been shown to have a great effect on tumor development with macrophages being the major cell type within the TME. Macrophages can inherit an inflammatory M1 or an anti-inflammatory M2 phenotype. Tumor-associated macrophages, which are predominantly polarized to M2, favor tumor growth, angiogenesis, and metastasis. In this review, we aimed to describe the complex roles and functions of lncRNAs in macrophages and their influence on lung cancer development and progression through the TME. MDPI 2021-08-17 /pmc/articles/PMC8392679/ /pubmed/34439281 http://dx.doi.org/10.3390/cancers13164127 Text en © 2021 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Review Karger, Annika Nandigama, Rajender Stenzinger, Albrecht Grimminger, Friedrich Pullamsetti, Soni Savai Seeger, Werner Savai, Rajkumar Hidden Treasures: Macrophage Long Non-Coding RNAs in Lung Cancer Progression |
title | Hidden Treasures: Macrophage Long Non-Coding RNAs in Lung Cancer Progression |
title_full | Hidden Treasures: Macrophage Long Non-Coding RNAs in Lung Cancer Progression |
title_fullStr | Hidden Treasures: Macrophage Long Non-Coding RNAs in Lung Cancer Progression |
title_full_unstemmed | Hidden Treasures: Macrophage Long Non-Coding RNAs in Lung Cancer Progression |
title_short | Hidden Treasures: Macrophage Long Non-Coding RNAs in Lung Cancer Progression |
title_sort | hidden treasures: macrophage long non-coding rnas in lung cancer progression |
topic | Review |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8392679/ https://www.ncbi.nlm.nih.gov/pubmed/34439281 http://dx.doi.org/10.3390/cancers13164127 |
work_keys_str_mv | AT kargerannika hiddentreasuresmacrophagelongnoncodingrnasinlungcancerprogression AT nandigamarajender hiddentreasuresmacrophagelongnoncodingrnasinlungcancerprogression AT stenzingeralbrecht hiddentreasuresmacrophagelongnoncodingrnasinlungcancerprogression AT grimmingerfriedrich hiddentreasuresmacrophagelongnoncodingrnasinlungcancerprogression AT pullamsettisonisavai hiddentreasuresmacrophagelongnoncodingrnasinlungcancerprogression AT seegerwerner hiddentreasuresmacrophagelongnoncodingrnasinlungcancerprogression AT savairajkumar hiddentreasuresmacrophagelongnoncodingrnasinlungcancerprogression |